My ePortfolio Register   

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.04.17
Views: 1082

Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA

Jessica Yasmine Islam speaks with ecancer at AACR 2017 about the changing burden of disease for HIV citizens who develop cancer.

She notes the increased availability of life-extending anti-retroviral drugs, resulting in HIV patients living long enough to increase their risk of developing non-AIDS related cancers, and that by 2030 over 20% of HIV patients are projected to live over 65 years.

You can read more about these findings here.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence